Claritas HealthTech’s subsidiary, Intelligent Scopes Corp (ISC), will take the lead in the global deployment of CystoSmart™, an AI diagnostic tool for bladder cancer detection. The technology, developed by Claritas in collaboration with Singapore’s Khoo Teck Puat Hospital (KTPH) and the National Healthcare Group’s Centre for Medical Technologies and Innovations (CMTi), aims to enhance the accuracy and efficiency of bladder cancer diagnostics.
Bladder cancer is a prevalent form of cancer, ranking as the 10th most common worldwide and the 6th most common among men. However, diagnosing the condition through cystoscopy examinations can be challenging and resource-intensive. CystoSmart™ offers a groundbreaking solution with superior detection rates and is currently undergoing FDA review for clearance.
Dr. Laszlo Neumann, CTO of Claritas, expressed excitement about working with the clinical team from Singapore to develop CystoSmart™. The joint objective has been to create a precise AI tool that can aid clinicians in significantly improving patient care.
Dr. Siying Yeow, clinical principal investigator for CystoSmart™ and consultant urologist at KTPH, has also expressed satisfaction with the progress made in developing the AI diagnostic tool. The goal has been to enhance the accuracy of bladder cancer detection and enable appropriate treatment for newly diagnosed cancers, accurate recognition of tumor recurrences, and complete tumor resection during surgery.
Claritas HealthTech is a leader in image enhancement and AI diagnostic solutions, focusing on medical image processing and AI-assisted interpretation and diagnostics. The company aims to transform the diagnostics industry by providing powerful and effective software products created using image enhancement and AI technology.
Intelligent Scopes Corp specializes in image processing, image enhancement, AI diagnostic tools, and robotic guidance systems for endoscopy in the fields of urology and gastroenterology. Their cutting-edge solutions aim to improve detection rates, reduce unnecessary biopsies, and enhance patient outcomes.
Khoo Teck Puat Hospital (KTPH) is a 795-bed general and acute care public hospital in Singapore. As part of the National Healthcare Group (NHG), KTPH serves over 550,000 people residing in the northern sector of Singapore.
The global deployment of CystoSmart™ under the leadership of ISC highlights the significance of AI technology in revolutionizing medical diagnostics. By providing accurate and efficient detection of bladder cancer, this innovative tool has the potential to improve patient outcomes and contribute to the advancement of healthcare worldwide.
For media inquiries or further information regarding Claritas HealthTech and Intelligent Scopes Corp, please visit their respective websites.
